Abstract:The character of DNA replication is high fidelity. Precise and complete DNA replication is critical for the maintenance of genetic stability. Failures in these processes are major sources of genomic instability and will lead to cancer or other diseases. A wide variety of factors, such as DNA replication errors, spontaneous chemical reactions, reactive metabolic products, exogenous environmental agents or some anticancer therapeutics e.g. 5’-aza-2’-deoxycytidine (5-Aza-CdR), can cause DNA damage (Wang et al, 2008; Zhu et al, 2004; Chai et al, 2008; Hoeijmakers, 2009). It is estimated that DNA damage occurs at a rate of 1,000 to 1,000,000 molecular lesions per cell per day (Lodish, 2004). In order to deal with problems under which the genome is vulnerable to injury or replication stress, eukaryotic cells elaborate a genomic maintenance apparatus, which is termed the DNA damage response (DDR) and replication stress response, including various checkpoint, signal-transduction and effectors system, which monitor problems and trigger a comprehensive cellular response pathway to prevent genome integrity. The extent of DNA damage depends on the type of environment to which it is exposed (Hoeijmakers, 2001). So, organisms must be capable of recognizing and dealing with each type of damage. It is not surprising that there are various different types of DNA damage response and repair systems. ATM and ATR are at the top of the DNA damage pathways. Although a cross-talk exists between the ATM and ATR pathways, ATM primarily seems to be involved in the detection of DNA double-strand breaks via Mre11/Rad50/Nbs1 complex (MRN), ATR is critical for cellular responses to a variety of DNA damage and stalled replication forks (Hefferin & Tomkinson, 2005). When these protein kinases activated, they eventually phosphorylate and modulate the downstream effectors (e.g., Chk1 and Chk2) and multiple additional substrates that initiate the cellular responses. Dynamic changes in protein post-translational modifications play a significant role in most cellular signalling pathways. More and more proteins were found in a variety of posttranslational modifications in response to DNA damage and genotoxic stress, such as phosphorylation, acetylation, sumolyation, methylation and ubiquitylation. Recent studies indicate that a crosstalk between multiple protein modifications exists, which collaboratively regulates signal transduction of DNA damage and genetic stresses.

The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer.

DNA damage checkpoint kinases in cancer

Targeting DNA checkpoint kinases in cancer therapy.

ATM and ATR：Sensing DNA Damage

Targeting Chk2 Kinase: Molecular Interaction Maps and Therapeutic Rationale

ATM, ATR and DNA Damage-Induced Cell Cycle Arrest

Recent Advances in Cancer Therapy Targeting Proteins Involved in DNA Double-Strand Break Repair

Roles of ATM and ATR in DNA double strand breaks and replication stress

Mammalian Chk2 is a Downstream Effector of the ATM-dependent DNA Damage Checkpoint Pathway

Mystery of DNA repair: the role of the MRN complex and ATM kinase in DNA damage repair

Tip60: Connecting Chromatin to DNA Damage Signaling.

ATM: Main Features, Signaling Pathways, and Its Diverse Roles in DNA Damage Response, Tumor Suppression, and Cancer Development

The post translational modification of key regulators of ATR signaling in DNA replication

DNA Damage Checkpoint Recovery and Cancer Development

Targeting the ATM pathway in cancer: Opportunities, challenges and personalized therapeutic strategies

Damage and Replication Stress Responses

Chk2 Phosphorylation of BRCA1 Regulates DNA Double-Strand Break Repair

DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis

Ataxia-telangiectasia-mutated (ATM) and NBS1-dependent Phosphorylation of Chk1 on Ser-317 in Response to Ionizing Radiation

ATM controls the extent of DNA end resection by eliciting sequential posttranslational modifications of CtIP

Targeting DNA damage response pathways in cancer